Atlas Trials

Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.

Clinical trial NCT05083494 · UNKNOWN

Trial details

NCT number
NCT05083494
Sponsor
Assistance Publique Hopitaux De Marseille
Status
UNKNOWN
Study type
OBSERVATIONAL
Cancer
Start date
2021-04-09
Primary completion
2023-04-01
Enrollment
260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.